Diffuse large B-cell lymphoma with extra Bcl-2 gene signals detected by FISH analysis is associated with a "non-germinal center phenotype"
- PMID: 16006802
Diffuse large B-cell lymphoma with extra Bcl-2 gene signals detected by FISH analysis is associated with a "non-germinal center phenotype"
Abstract
Amplification and translocation of the Bcl-2 gene has been detected in a certain subset of diffuse large B-cell lymphomas (DLBCL). The correlations among Bcl-2 protein expression, gene translocation or amplification, and the molecular signature determined by cDNA array are poorly understood. This study examined 25 cases with de novo nodal DLBCL. Interphase fluorescence in situ hybridization (FISH) analysis was performed to evaluate the Bcl-2 gene using IGH/BCL2 and CEP18 centromere probes (Vysis). When extra Bcl-2 gene signals were observed in each tumor cell and when these signals were in proportion to the extra CEP18 probe signals, we regarded the findings as indicating the presence of an additional chromosome 18; when extra Bcl-2 signals were observed but additional CEP18 signals were not, we regarded the findings as indicating the presence of gene amplification. A panel of 3 antigens (CD10, Bcl-6, and MUM-1) was applied to categorize each case as either a "germinal center B-cell (GCB) phenotype" or a "non-GCB phenotype." Of the 25 cases examined, 8 cases (32%) were classified as "GCB phenotype" and 17 cases (68%) were classified as "non-GCB phenotype." A FISH analysis revealed that t(14;18) was detected in 2 of the 8 cases (25%) with the "GCB phenotype" but in none of the 17 "non-GCB phenotype" cases. Extra Bcl-2 gene signals were detected in 7 of the 25 (28%) cases examined: n = 5 for an additional chromosome 18, n = 1 for gene amplification, and n = 1 for additional chromosome 18 + gene amplification. Extra Bcl-2 gene signals were exclusively detected in DLBCL with the "non-GCB phenotype"; these cases, with the exception of one, stained strongly positive for Bcl-2. The DLBCLs with Bcl-2 protein overexpression were classified into at least two heterogeneous molecular groups, based on the results of the FISH analysis.
Similar articles
-
The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome.Clin Cancer Res. 2003 Jun;9(6):2133-9. Clin Cancer Res. 2003. PMID: 12796378
-
Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma.Clin Cancer Res. 2008 May 15;14(10):3002-10. doi: 10.1158/1078-0432.CCR-07-4946. Epub 2008 Apr 29. Clin Cancer Res. 2008. PMID: 18445693
-
Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping.Cancer. 2003 Dec 25;99(6):385-93. doi: 10.1002/cncr.11787. Cancer. 2003. PMID: 14681948 Clinical Trial.
-
[Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].Gan To Kagaku Ryoho. 2007 Jul;34(7):975-82. Gan To Kagaku Ryoho. 2007. PMID: 17637530 Review. Japanese.
-
Usefulness of immunohistochemistry in identification of prognostically important subgroups (GCB and ABC) in a heterogeneous group of diffuse large B-cell lymphomas--a review article.Pol J Pathol. 2008;59(3):121-7. Pol J Pathol. 2008. PMID: 19097355 Review.
Cited by
-
Prognostic Significance of in situ Phenotypic Marker Expression in Diffuse Large B-cell Lymphomas.Biomark Insights. 2007 Nov 11;2:403-17. Biomark Insights. 2007. PMID: 19662221 Free PMC article.
-
Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCL.Gastric Cancer. 2014;17(3):431-41. doi: 10.1007/s10120-013-0313-3. Epub 2013 Nov 14. Gastric Cancer. 2014. PMID: 24232982
-
Efficacy of dose-adjusted EPOCH plus rituximab/R-CHOP regimens and the prognosis analysis in patients with MYC, BCL2/BCL6 gene copy number gain lymphoma and double-hit lymphoma: results from a single institution retrospective clinical study.Cancer Manag Res. 2019 Feb 11;11:1363-1372. doi: 10.2147/CMAR.S192143. eCollection 2019. Cancer Manag Res. 2019. PMID: 30809101 Free PMC article.
-
Immunohistochemical and molecular characteristics with prognostic significance in diffuse large B-cell lymphoma.PLoS One. 2014 Jun 2;9(6):e98169. doi: 10.1371/journal.pone.0098169. eCollection 2014. PLoS One. 2014. PMID: 24887414 Free PMC article.
-
Dysregulation of Cell Survival in Diffuse Large B Cell Lymphoma: Mechanisms and Therapeutic Targets.Front Oncol. 2019 Mar 1;9:107. doi: 10.3389/fonc.2019.00107. eCollection 2019. Front Oncol. 2019. PMID: 30881917 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials